Literature DB >> 12654717

Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism.

Giorgio Mello1, Elena Parretti, Francesca Gensini, Elena Sticchi, Federico Mecacci, Gianfranco Scarselli, Maurizio Genuardi, Rosanna Abbate, Cinzia Fatini.   

Abstract

The risk for an adverse pregnancy outcome is markedly higher in women with history of preeclampsia. This may stem from impaired placentation in early gestation and from high impedance to flow in uteroplacental circulation. The renin-angiotensin system is one of the mediators of the remodeling of spiral arteries throughout pregnancy. The D allele of the Insertion/Deletion (I/D) polymorphism in the ACE gene has been associated with higher ACE activity, accounting for 47% of the total phenotypic variance of serum enzyme levels. To investigate whether the ACE I/D polymorphism affects maternal uteroplacental and fetal umbilical circulation and the pregnancy outcome in women with a history of preeclampsia, 106 women underwent Doppler examination of uterine arteries resistance index and umbilical artery pulsatility index at the 16th, 20th, and 24th weeks of gestation and were genotyped for the I/D polymorphism. This study found a difference in genotype distribution (P=0.0002) and allele frequency (P<0.0001) between women with and those without preeclampsia recurrence and fetal growth restriction as well as an association (P=0.0007) between DD genotype and risk of recurrent preeclampsia or fetal growth restriction. At the 16th, 20th, and 24th weeks, uterine artery resistance indexes were significantly lower in II, higher in DD, and intermediate in ID genotype carriers, whereas the umbilical artery pulsatility index values were significantly higher in the DD group in comparison to ID and II genotypes. The current study shows that the ACE I/D polymorphism affects uteroplacental and umbilical flows and the recurrence of an adverse pregnancy outcome in women with history of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654717     DOI: 10.1161/01.HYP.0000063146.40351.AD

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

Review 1.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

Review 2.  The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.

Authors:  Christos Yapijakis; Iphigenia Gintoni; Maria Adamopoulou
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 3.  Angiotensin-converting enzyme insertion/deletion (I/D) polymorphisms and recurrent pregnancy loss: a meta-analysis.

Authors:  Chen Yang; Wu Fangfang; Li Jie; Yang Yanlong; Wang Jie; Liang Xuefei; Zhang Xuerong; Hu Yanling
Journal:  J Assist Reprod Genet       Date:  2012-10-07       Impact factor: 3.412

4.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

5.  Race, genes and preterm delivery.

Authors:  Kevin Fiscella
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

6.  Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.

Authors:  Astrid Dossenbach-Glaninger; Mick van Trotsenburg; Christian Oberkanins; Johanna Atamaniuk
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

7.  Studies on angiotensin-converting enzyme insertion/deletion polymorphism and genotype distributions in Turkish preeclampsia patients.

Authors:  Ceyhun Bereketoğlu; Mülkiye Kasap; Ayfer Pazarbaşı
Journal:  J Pregnancy       Date:  2012-03-25

8.  Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias.

Authors:  Norma C Serrano; Luis A Díaz; Maria C Páez; Clara M Mesa; Rodrigo Cifuentes; Alvaro Monterrosa; Adriana González; Liam Smeeth; Aroon D Hingorani; Juan P Casas
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

9.  Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia.

Authors:  Hyunah Choi; Ja Young Kang; Hong Sun Yoon; Seung Suk Han; Chang Sun Whang; In Gul Moon; Hyun-Ho Shin; Jeong Bae Park
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

Review 10.  Genetic aspects of preeclampsia and the HELLP syndrome.

Authors:  Kjell Haram; Jan Helge Mortensen; Bálint Nagy
Journal:  J Pregnancy       Date:  2014-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.